期刊文献+

结核病短程化疗及其复发的机制和对策 被引量:1

Tuberculosis DOTS and its Recurrence and Countermeasures
暂未订购
导出
摘要 短程化疗是治疗结核病的重要手段,应根据患者的实际情况,选择适宜的化学治疗方案。短程化疗是世界卫生组织推荐使用的治疗方法,其疗效已经得到肯定。但各地应根据疗效分析,研究短程化疗后复发的机制和影响因素,采取加强用药管理、用原方案重复治疗、随访一年、应用含有INH-RFP及PZA的抗结核化疗方案以及合理应用链霉素和乙胺丁醇等措施,使患者得到及早康复。 DOTS is an important means of treatment of tuberculosis should be based on the actual situation of the patient,choose the appropriate chemical treatment. DOTS is the World Health Organization recommended treatment method used,its efficacy has been affirmed. But over the analysis should be based on efficacy, mechanism and influencing factors of recurrence after short-course chemotherapy, medication taken to strengthen management, repeat treatment with the original plan, a year of follow-up, anti-TB chemotherapy application containing INH-RFP and PZA and the rational use of streptomycin and ethambutol and other measures, so that patients get speedy recovery.
作者 祁锦辉
出处 《中国卫生产业》 2015年第28期59-61,共3页 China Health Industry
关键词 短程化疗 结核病 复发 对策 DOTS Tuberculosis Relapse Countermeasures
  • 相关文献

参考文献4

二级参考文献11

  • 1赵丰曾,中华结核和呼吸杂志,1995年,18卷,19页
  • 2池延花,中国防痨杂志,1994年,16卷,147页
  • 3赵丰曾,中国防痨杂志,1993年,15卷,103页
  • 4Aziz MA,Wright A.The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance:a model for other infectious diseases.Clin Infect Dis,2005,41 Suppl 4:S258-S262.
  • 5Espinal MA,Laszlo A,Simonsen L,et al.Global trends in resistance to antituberculosis drugs.World Health OrganizationInternational Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.N Engl J Med,2001,344:1294-1303.
  • 6World Health Organization.Anti-tuberculosis drug resistance in the world:third global report/the WHO/IUATLD global project on antituberculosis drug resistance surveillance,1999-2002.WHO/HTM/TB/2004.343.Geneva:WHO,2004.44-70.
  • 7Wang G,Peng YL,Zhang G,et al.Sample survey of drug-resistant tuberculosis in Henan,China,1996.Respirology,2002,7:67-72.
  • 8Noeske J,Nguenko PN.Impact of resistance to anti-tuberculosis drugs on treatment outcome using World Health Organization standard regimens.Trans R Soc Trop Med Hyg,2002,96:429-433.
  • 9严碧涯.浅谈结核病学进展[J]中国防痨通讯,1987(04).
  • 10李群,王晓萌,何海波,何铁牛,韩永兴,孙颂文,姚强,朱一凡,徐旭卿.WHO浙江省结核病耐药监测研究报告[J].中华结核和呼吸杂志,2000,23(12):718-721. 被引量:88

共引文献53

同被引文献15

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部